Home » Science and Research Articles » Dr. Afsaneh Motamed-Khorasani, Ph.D. to be Profiled in Exclusive Registry
Dr. Afsaneh Motamed-Khorasani, Ph.D. to be Profiled in Exclusive Registry
Dr. Motamed-Khorasani has a diverse background in clinical trials, basic research, intellectual property, and industry
Toronto, ON, Canada, December 27, 2010 /Science and Research PR News/ -- Afsaneh Motamed-Khorasani, CEO and Director of Medical Communication at Neometrix Consulting Inc. (NCI), has been recognized by Cambridge Who's Who for demonstrating scientific dedication, leadership and excellence in medical communication and research.
Dr. Motamed-Khorasani has 15 years of professional experience in the field of scientific research and medical communication. As a CEO and Director of Medical Communication at NCI, she oversees all aspects of company activities including medical communication, marketing and client relations. She attributes her success to her passion for science, personal optimism and networking skills.
While earning a Ph.D. in oncology, Dr. Motamed-Khorasani was honored with numerous fellowships and awards of excellence at the University of British Columbia and the University of Toronto. Her many affiliations include American Association of Cancer Research (AACR), Endocrine Society, The Intellectual Property Institute of Canada (IPIC), The Toronto Biotechnology Initiative (TBI) and The Iranian-American Medical Association (IAMA). A supporter of the Heart and Stroke Foundation of Canada, Dr. Motamed-Khorasani intends to continue consulting at the international level.
Neometrix Consulting Inc. is a Canadian based consultancy offering medical communication and medical intelligence services to the pharmaceutical, biotechnology, and medical device companies, clinics, hospitals, contract research organizations (CRO), government agencies, and academic institutes. It strives to develop strategic platforms and processes, enabling clients to make highly informed decisions, reduce costs, create value and improve performance. The clinical areas of NCI expertise are oncology, hepatology, immunology, bone health, rheumatoid arthritis, blood products, neurology, cardiology, infectious disease, diabetes, urology, reproductive medicine, and pharmacogenetics. For more information, visit http://neometrixconsulting.com.
About Cambridge Who's Who
With over 400,000 members representing every major industry, Cambridge Who's Who is a powerful networking resource that enables professionals to outshine their competition, in part through effective branding and marketing. Cambridge Who's Who employs similar public relations techniques to those utilized by Fortune 500 companies and makes them cost-effective for members who seek to take advantage of its career enhancement and business advancement services. Cambridge is pleased to welcome its new Executive Director of Global Branding and Networking, Donald Trump Jr., who is eager to share his extensive experience in this arena with members.
Cambridge Who's Who membership provides individuals with a valuable third party endorsement of their accomplishments and gives them the tools needed to brand themselves and their businesses effectively. In addition to publishing biographies in print and electronic form, it offers an online networking platform where members can establish new professional relationships.
For more information, please visit http://www.cambridgeregistry.com.
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com |
|
|
Press Release Contact Information:
Ellen Campbell
Cambridge Who's Who
Public Relations
498 RXR Plaza, West Tower
Uniondale, NY
USA 11556
Voice: 516-535-1515 x4266
Website: Visit Our Website |
|
|
|
|
| SCIENCE AND RESEARCH ARCHIVE SEARCH |
|
|
| |
| SUBMIT SCIENCE AND RESEARCH NEWS |
|
|
| |
|
|
Advertise With Us |
About Us |
Contact Us